TNF and benign prostatic hyperplasia: Since patients with AI disease have an elevated BPH prevalence compared to patients without AI disease, a similar comparison of the BPH incidence in patients taking methotrexate or TNF-antagonists to that of patients not taking medication within each AI disease was performed.